Stocks and Investing
Stocks and Investing
Tue, November 6, 2012
[ 05:40 AM ] - United States, WOPRAI
[ 05:30 AM ] - United States, Market Wire
[ 05:15 AM ] - United States, Market Wire
[ 04:23 AM ] - United States, WOPRAI
[ 04:23 AM ] - United States, WOPRAI
[ 04:23 AM ] - United States, WOPRAI
[ 04:22 AM ] - United States, WOPRAI
[ 04:22 AM ] - United States, WOPRAI
[ 04:21 AM ] - United States, WOPRAI
[ 04:21 AM ] - United States, WOPRAI
[ 04:21 AM ] - United States, WOPRAI
[ 04:20 AM ] - United States, WOPRAI
[ 04:20 AM ] - United States, WOPRAI
[ 02:23 AM ] - United States, WOPRAI
[ 02:22 AM ] - United States, WOPRAI
[ 02:22 AM ] - United States, WOPRAI
[ 02:22 AM ] - United States, WOPRAI
[ 02:22 AM ] - United States, WOPRAI
[ 02:21 AM ] - United States, WOPRAI
[ 02:21 AM ] - United States, WOPRAI
[ 02:21 AM ] - United States, WOPRAI
[ 02:21 AM ] - United States, WOPRAI
[ 02:20 AM ] - United States, WOPRAI
[ 02:20 AM ] - United States, WOPRAI
[ 02:00 AM ] - United States, Market Wire
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Gena Wang Maintained (BMRN) at Buy with Increased Target to $54 on, Nov 6th, 2012
Gena Wang of Barclays, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Buy with Increased Target from $46 to $54 on, Nov 6th, 2012.
Gena has made no other calls on BMRN in the last 4 months.
There are 4 other peers that have a rating on BMRN. Out of the 4 peers that are also analyzing BMRN, 1 agrees with Gena's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Andrew Peters of "Deutsche Bank" Downgraded from Strong Buy to Hold and Held Target at $45 on, Monday, August 27th, 2012
These are the ratings of the 3 analyists that currently disagree with Gena
- Michelle Gilson of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $56 on, Monday, November 5th, 2012
- Cory Kasimov of "JP Morgan" Maintained at Buy with Increased Target to $50 on, Thursday, September 27th, 2012
- Matthew Harrison of "Morgan Stanley" Maintained at Strong Buy with Increased Target to $52 on, Monday, July 23rd, 2012
Contributing Sources